Substance P induces adverse myocardial remodelling via a mechanism involving cardiac mast cells

GC Melendez, J Li, BA Law, JS Janicki… - Cardiovascular …, 2011 - academic.oup.com
Aims Substance P and neurokinin A (NKA) are sensory nerve neuropeptides encoded by
the TAC1 gene. Substance P is a mast cell secretagogue and mast cells are known to play a …

Substance P acting via the neurokinin-1 receptor regulates adverse myocardial remodeling in a rat model of hypertension

HM Dehlin, EJ Manteufel, AL Monroe… - International journal of …, 2013 - Elsevier
Background Substance P is a sensory nerve neuropeptide located near coronary vessels in
the heart. Therefore, substance P may be one of the first mediators released in the heart in …

Substance P-mediated cardiac mast cell activation: An in vitro study

SP Levick, GL Brower, JS Janicki - Neuropeptides, 2019 - Elsevier
The neuropeptide substance P can induce degranulation of cardiac mast cells at high
concentrations. Herein, we seek to further understand substance P activation of cardiac mast …

[HTML][HTML] Regulation of cardiac mast cell maturation and function by the neurokinin-1 receptor in the fibrotic heart

A Widiapradja, EJ Manteufel, HM Dehlin, J Pena… - Scientific Reports, 2019 - nature.com
Cardiac fibrosis is an underlying cause of diastolic dysfunction, contributing to heart failure.
Substance P (SP) activation of the neurokinin-1 receptor (NK-1R) contributes to cardiac …

Substance P in heart failure: the good and the bad

HM Dehlin, SP Levick - International journal of cardiology, 2014 - Elsevier
The tachykinin, substance P, is found primarily in sensory nerves. In the heart, substance P-
containing nerve fibers are often found surrounding coronary vessels, making them ideally …

Mast cells and ɛPKC: A role in cardiac remodeling in hypertension-induced heart failure

SS Palaniyandi, K Inagaki, D Mochly-Rosen - Journal of molecular and …, 2008 - Elsevier
Heart failure (HF) is a chronic syndrome in which pathological cardiac remodeling is an
integral part of the disease and mast cell (MC) degranulation-derived mediators have been …

Protection from adverse myocardial remodeling secondary to chronic volume overload in mast cell deficient rats

SP Levick, JD Gardner, M Holland… - Journal of molecular and …, 2008 - Elsevier
Mast cells have diverse roles throughout the body as evidenced by their heterogeneous
nature. In the heart, cardiac mast cells have been implicated in left ventricular (LV) …

The role of substance P in myocardial dysfunction during ischemia and reperfusion

H Chiao, RW Caldwell - Naunyn-Schmiedeberg's archives of …, 1996 - Springer
Impairment of myocardial contraction (“myocardial stunning”) occurs during reperfusion after
short ischemic periods. Substance P (SP) is widely distributed in heart and can be released …

Substance P induces cardioprotection in ischemia-reperfusion via activation of AKT

S Jubair, J Li, HM Dehlin… - American Journal …, 2015 - journals.physiology.org
Accumulating evidence indicates that substance P is cardioprotective following ischemia-
reperfusion primarily due to its potent coronary vasodilator actions. However, an anti …

Implication of Substance P in myocardial contractile function during ischemia in rats

LL Wang, Z Guo, Y Han, PF Wang, RL Zhang… - Regulatory peptides, 2011 - Elsevier
Evidence suggests that substance P (SP) participates in the pathology of acute myocardial
ischemia and infarction but the profiles of the peptide in regulation of cardiac functions are …